Home > Market > Market Stats > Rossari Biotech

Rossari Biotech Share Price

Sector: Chemical Manufacturing

598.75 0.00 (0.00%)

Price Range

Today’s Low 0.0

Today’s High 0.0

52 Week Low 536.1

52 Week High 1051.0

Key Metrics

Market Cap (In Cr) 3309.05
Beta -
Div. Yield (%) 0.08
P/B 4.1
TTM P/E 38.99
Peg Ratio 2.35
Sector P/E 13.21
D/E -
Open Price 0
Prev Close 598.75

View All Metrics on Mint Genie

Rossari Biotech Analysis

Price Analysis

1 Week

7.39%
3 Months

-17.71%
6 Month

-37.65%
YTD

-17.49%
1 Year

-35.78%

Risk Meter

23% Low risk
23% Moderate risk
23% Balanced Risk
23% High risk
23% Extreme risk

Recos

3 Analysts

Strong Sell
Sell
Hold
Buy
Strong Buy

Analysts' Views

Ratings
Current

Strong Sell
0

Sell
0

Hold
0

Strong Buy
1

Rossari Biotech Financials

INCOME
BALANCE SHEET
Cashflow

DATE

Annual

Quarterly

Period
2022

Total Revenue
1482.97

Selling/ General/ Admin Expenses Total
179.27

Depreciation/ Amortization
48.06

Other Operating Expenses Total
15.17

Total Operating Expense
1342.66

Operating Income
140.31

Net Income Before Taxes
136.28

Net Income
97.67

Diluted Normalized EPS
16.8

Period
2021

Total Revenue
709.34

Selling/ General/ Admin Expenses Total
117.45

Depreciation/ Amortization
22.83

Other Operating Expenses Total
6.64

Total Operating Expense
609.11

Operating Income
100.24

Net Income Before Taxes
106.84

Net Income
80.22

Diluted Normalized EPS
15.4

Period
2020

Total Revenue
600.09

Selling/ General/ Admin Expenses Total
116.57

Depreciation/ Amortization
16.85

Other Operating Expenses Total
5.38

Total Operating Expense
512.13

Operating Income
87.96

Net Income Before Taxes
87.84

Net Income
65.25

Diluted Normalized EPS
12.86

Period
2019

Total Revenue
516.22

Selling/ General/ Admin Expenses Total
92.8

Depreciation/ Amortization
12.26

Other Operating Expenses Total
3.99

Total Operating Expense
450.58

Operating Income
65.64

Net Income Before Taxes
63.39

Net Income
45.68

Diluted Normalized EPS
9

Period
2018

Total Revenue
299.06

Selling/ General/ Admin Expenses Total
48.13

Depreciation/ Amortization
5.17

Other Operating Expenses Total
2.24

Total Operating Expense
261.43

Operating Income
37.63

Net Income Before Taxes
37.47

Net Income
25.4

Diluted Normalized EPS
5.01

Period
2017

Total Revenue
233.38

Selling/ General/ Admin Expenses Total
37.16

Depreciation/ Amortization
4.27

Other Operating Expenses Total
0.47

Total Operating Expense
213.08

Operating Income
20.3

Net Income Before Taxes
18.73

Net Income
13.99

Diluted Normalized EPS
2.7

View detailed financials on Mint Genie

Forecast

Income Sheet (In Cr) Net Income Vs Revenue

Returns Metrics (In Cr) ROA Vs ROE

Forecast

Balance Sheet Asset vs Liability

Forecast

Cash Flow Operating vs Investing

Rossari Biotech Peers

Price
Ratio

Name
Latest Price
Change
% Change
52W High
52W Low
Mkt. Cap

NOCIL
212
0.3
0.14
294.85
200.35
3531.37

Ami Organics
917.55
-16.95
-1.81
1182.4
826
3343.28

Rossari Biotech
598.75
0
0
1051
536.1
3296.5

Neogen Chemicals
1285.35
-4
-0.31
1792
1127.7
3205.58

Dhanuka Agritech
648.6
-7.45
-1.14
797.35
630.65
3021.07

Rossari Biotech Shareholding

Category
Percentage
No. of shares

Public Shareholding
31.56%
17,406,386

SBI Small Cap Fund
6.89%
3,799,818

UTI Flexi Cap Fund
4.1%
2,259,334

Idfc Focused Equity Fund
1.44%
793,261

Others
0.21%
120,245

Stichting Depositary Apg Emerging Markets Equity Pool
1.6%
881,497

Taiyo Greater India Fund Ltd
1.24%
683,763

Goldman Sachs Funds - Goldman Sachs India Equity Portfolio
1.21%
666,135

UTI India Dynamic Equity Fund
1.19%
653,894

Others
3.39%
1,876,875

Others
6.15%
3,392,898

ICICI Lombard General Insurance Company Ltd
1.32%
727,778

Others
0.02%
8,714

Others
1.02%
563,586

Others
0.82%
451,807

Others
0.38%
208,747

Others
0.25%
135,845

HUF
0.15%
81,010

LLP
0.04%
21,774

Clearing Members
0.04%
20,076

Trusts
0%
135

Others
0.1%
55,694

Others
0.01%
3,500

Promoter & Promoter Group Shareholding
68.44%
37,745,500

Edward Menezes
29.23%
16,118,820

Sunil Srinivasan Chari
29.17%
16,089,320

Anita Menezes
1.82%
1,002,630

Jyotishna Sunil Chari
1.81%
1,000,330

Yash Sunil Chari
0.3%
165,000

Mikhail Menezes
0.24%
133,200

Rossari Biotech India Private Limited
5.47%
3,016,200

Chari Family Trust - in the name of Sunil Srinivasan Chari
0.2%
110,000

Menezes Family Trust - in the name of Edward Walter Menezes
0.2%
110,000

Shareholding Pattern

Shareholding Trend

Shareholding(%) v/s Date

Corporate Actions

Board Meeting
AGM
Dividends
Bonus
Split
Rights

Meeting Date
Purpose

04-Feb-23
Quarterly Results

05-Nov-22
Quarterly Results

06-Aug-22
Quarterly Results

19-May-22
Audited Results & Final Dividend

14-Feb-22
Quarterly Results

29-Jan-22
Quarterly Results

30-Oct-21
Quarterly Results

30-Jul-21
Quarterly Results

14-May-21
Audited Results & Final Dividend

23-Jan-21
Quarterly Results

Meeting Date
Announced on
Purpose

15-Jul-22
20-May-22
AGM

-
30-Jul-21
AGM

Announced on
Record Date
Ex-Dividend
Dividend Value

20-May-22
-
07-Jul-22
0.5

14-May-21
-
08-Sept-21
0.5

Company Profile

ABOUT Rossari Biotech

Industry Chemical Manufacturing
ISIN INE02A801020
BSE Code 543213
NSE Code ROSSARI

Rossari Biotech Limited is an India-based company. The Company is engaged in manufacturing, selling and distribution of specialty chemicals. The products cater to global brands in the FMCG sector and find applications in a host of consumer centric products and home and personal care products, textile chemicals, animal health and nutrition and cosmetic products. It operates through three segments: Home, Personal Care and Performance Chemicals (HPPC), Textile Specialty Chemicals (TSC), and Animal Health and Nutrition (AHN). HPPC produces acrylic polymers, manufacturing a sustainable range of products for various applications in the cleaning industry. TSC is focused on providing customers with eco-friendly, sustainable chemical solutions. It provides solutions for pre-treatment, dyeing and printing, finishing, and specialty chemicals for the entire value chain of the textile industry. AHN provides wellness solutions for pet animals and poultry, focusing on their health and performance.

MANAGEMENT

Edward Menezes Executive Chairman of the Board, Co-Founder
Sunil Chari Managing Director, Co-Founder, Executive Director
Manasi Nisal Chief Financial Officer
Parul Gupta Compliance Officer, Company Secretary

ROSSARI BIOTECH SUMMARY

Rossari Biotech is trading 0.00% lower at Rs 598.75 as compared to its last closing price. Rossari Biotech has been trading in the price range of 0.0 & 0.0. Rossari Biotech has given -17.49% in this year & 7.39% in the last 5 days.

Rossari Biotech has TTM P/E ratio 38.99 as compared to the sector P/E of 13.21. There are 3 analysts who have initiated coverage on Rossari Biotech. There are 1 analysts who have given it a strong buy rating & 2 analysts have given it a buy rating. 0 analysts have given the stock a sell rating.

The company posted a net profit of 25.68 Crores in its last quarter.

Listed peers of Rossari Biotech include NOCIL (0.14%), Ami Organics (-1.81%), Rossari Biotech (0%) etc.

Rossari Biotech has a 68.44% promoter holding & 31.56% public holding.

FAQs about Rossari Biotech

Rossari Biotech is trading at 598.75 as on -. This is 0.00% lower as compared to its previous closing price of 598.75

The market capitalization of Rossari Biotech is 3309.05 Cr as on -.

The average broker rating on Rossari Biotech is Strong Buy. The breakup of analyst rating is given below -

0 analysts have given a strong sell rating
0 analysts have given a sell rating
0 analysts have given a hold rating
2 analysts have given a buy rating
1 analysts have given a strong buy rating

The 52 wk high for Rossari Biotech is 1051.0 whereas the 52 wk low is 536.1

Rossari Biotech can be analyzed on the following key metrics -

TTM P/E: 38.99
Sector P/E: 13.21
Dividend Yield: 0.08%
D/E ratio: -

Rossari Biotech reported a net profit of 97.67 Cr in 2022.

Rossari Biotech Share Price

Price Range